HSP90AA1 and Burkitt lymphoma: As mentioned previously for the association of other signaling pathway inhibitors with HSP90 inhibitors, a synergistic anti-tumor effect was observed with PU-H71 and PI3K/mTOR inhibitors in BL [93].